Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 127,241 | 76,194 | 38,185 | 73,400 | 91,078 |
| Depreciation Amortization | 73,218 | 49,049 | 24,340 | 109,903 | 82,792 |
| Income taxes - deferred | 8,045 | 5,203 | 5,275 | -51,107 | -18,825 |
| Accounts receivable | -7,923 | 23,333 | 22,392 | 34,132 | 5,271 |
| Accounts payable and accrued liabilities | -2,953 | -8,107 | -2,115 | -13,954 | -639 |
| Other Working Capital | -45,117 | -40,996 | -42,849 | 11,539 | -10,031 |
| Other Operating Activity | 44,146 | 5,320 | -17,643 | 123,643 | 39,709 |
| Operating Cash Flow | $196,657 | $109,996 | $27,585 | $287,556 | $189,355 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 0 | 1,085 | 1,085 |
| PPE Investments | -20,370 | -11,284 | -5,363 | -31,006 | -26,116 |
| Purchase Of Investment | 0 | 0 | 0 | -15,000 | -15,000 |
| Other Investing Activity | 9,237 | 5,968 | 5,968 | 9,738 | 4,442 |
| Investing Cash Flow | $-11,133 | $-5,316 | $605 | $-35,183 | $-35,589 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | 104,000 | 38,000 |
| Debt Repayment | -146,000 | -86,000 | -46,000 | -77,000 | -27,000 |
| Common Stock Issued | 58,193 | 28,234 | 23,495 | 51,739 | 45,513 |
| Common Stock Repurchased | -24 | -24 | -24 | -275,731 | -175,674 |
| Dividend Paid | -37,432 | -24,914 | -12,444 | -50,391 | -38,004 |
| Other Financing Activity | -10,643 | -10,486 | -9,231 | -6,522 | -6,288 |
| Financing Cash Flow | $-135,906 | $-93,190 | $-44,204 | $-253,905 | $-163,453 |
| Exchange Rate Effect | -1,985 | -797 | -1,210 | 11,927 | -1,434 |
| Beginning Cash Position | 162,186 | 162,186 | 162,186 | 151,791 | 151,791 |
| End Cash Position | 209,819 | 172,879 | 144,962 | 162,186 | 140,670 |
| Net Cash Flow | $47,633 | $10,693 | $-17,224 | $10,395 | $-11,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | 196,657 | 109,996 | 27,585 | 287,556 | 189,355 |
| Capital Expenditure | -20,370 | -11,284 | -5,363 | -31,006 | -26,116 |
| Free Cash Flow | 176,287 | 98,712 | 22,222 | 256,550 | 163,239 |